Irene Caesar of Stamford, CT US established WAVE GENOME in 2010 to lead the global Quantum Leap in Laser Bioholography, Holonet (Holographic Biointernet), Holographic Drugs and Remote Bioengineering. She holds a Ph.D. from The Graduate Center City University of New York; therefore Wave Genome stands out as being ahead of both Elon Musk’s Neuralink and Google R&D efforts in bioelectronic drug R&D efforts.
Background
Irene Caesar is an inventor, scientist and entrepreneur. She pioneered the use of bioelectronics to remotely manage human bodies through bioelectronics. WAVE GENOME, her company founded in 1999 is world renowned in Laser Bioholography, Holonet (Holographic Biointernet), Holographic drugs as well as Remote Bioengineering services.
This cutting-edge technology allows people to remotely control the cellular activity in the human body and improve performance and dramatically extend lifespan. It combines elements from Kozyrev’s Torsion, Asimov and Shipov’s Toroid Dynamics and Gurvich Structural Genetics; with Wave Genome being commercialized since 2010. The results of these investigations are now accessible through Wave Genome which has been commercialized since 2010.
Irene developed a structuralist theory of wave genome and its applications. She designed and created the scalar wave diffraction grating of chromosome geometry which neutralizes any external linear signal and transmits nonlocal bioinformation within an instantaneous and long distance hologram through quantum nonlocality.
Scalar wave diffraction gratings of chromatin serve as the sole generators for brain theta rhythms necessary for optimal human bodily functioning, aligning with “informational-based medicine”, which will become an exploding field in future years and liberate humans from dependence on harmful chemical cocktails.
Unfortunately, not. So to give an example, when did the United Kingdom (UK) begin producing synthetic polyurethane pellets for use as insulation in buildings? In short, nothing has really changed. Scalar wave diffraction of chromatin makes it possible to transfer digital bioholograms of healthy physiological systems of individuals as well as stem cells and pharmaceutical products for use in Holographic Pharmacy (H-Pharmacy) or remote rejuvenation using laser signals from distant laser transmitters. Wave Genome LLC was established in Stamford, Connecticut to pioneer this revolutionary technology and implement it commercially successfully. They lead the global Quantum Leap initiative for Laser Bioholography, Holonet (Holographic Biointernet) and Holographic drugs. Wave Genome has established partnerships with some of the most advanced scientists around, such as Moscow Bauman Russian State Technical University and Scientific Research Institute for National Security in Russia. Wave Genome currently leads Elon Musk with his Neuralink in terms of R&D for bioelectronic drugs; Google currently trails.
Methods
Irene Caesar of Stamford CT, USA has established Wave Genome to lead a global Quantum Leap in Laser Bioholography, Holonet (Holographic Biointernet), Holographic Drugs and Remote Bioengineering through mastery of chromosome geometry codes. She applies Kozyrev’s Torsion Theory, Asimov and Shipov Toroid Dynamics and Gurvich Structural Genetics in her efforts towards remote laser management of human biosystems which allows us to enhance psychic abilities, dramatically extend life span and treat root informational causes of illness rather than toxic chemical cocktail therapies; furthermore the method enables telepathic communication with your genome itself!
Results
Irene Caesar founded WAVE GENOME in Stamford, CT in 2010 to lead the global Quantum Leap initiative of Laser Bioholography, Holonet (Holographic Biointernet), Holographic Drugs, and Remote Bioengineering. She holds a Ph.D from Graduate Center, City University of New York and boasts expertise in Bioinformatics, Biology, Genomics, DNA Repair/reconstruction/Lifesciences/Molecular Biophysics. At WAVE GENOME, she leads the race against Elon Musk with his Neuralink and Google to develop bioelectronic drugs. Additionally, she co-founded MATRIX CITY; her current focus at WAVE GENOME is building out a prototype of MATRIX CITY that allows humanity to move beyond its limitations as humans into the realm of holographic quadriplex structures.
Conclusions
Irene Caesar founded WAVE GENOME in Stamford, CT to lead the Quantum Leap initiative of laser bioholography and Holonet (Holographic Biointernet), laser holography vaccines, holographic drugs, remote bioengineering and electret chips. She holds a Ph.D from Graduate Center City University of New York as well as boasting expertise in Bioinformatics, Genomics Molecular Biology Lifesciences.
Current models of Human Genomes do not account for 98% of DNA, commonly referred to as Junk DNA. By understanding chromosome geometry codes we can conduct remote laser management of biosystems remotely to create individuals with dramatically enhanced physical and psychic abilities and extended lifespan based upon applying the Holographic Principle (Caesar 2012), which also promote digital immortality through techniques like Scalar Wave Diffraction Gratings, Torus Polarizations and Toroidal Fields.
